Becoming a Qualified Person in German pharma: the sachkundige Person route under § 15 AMG

No batch leaves a German pharmaceutical plant without a Qualified Person's signature. § 14 of the German Medicines Act makes the sachkundige Person a precondition of the manufacturing authorisation itself, and § 19 attaches personal responsibility for every single batch having been manufactured and tested according to the rules. It is the most tangible form of accountability pharma has to offer, and one of the few career steps whose requirements are written out, literally, in a statute.

And yet, in years of recruiting scientific and technical talent, I kept meeting strong QC and QA professionals who could describe the destination but not the road. This guide makes the road concrete, including for readers whose QP ambitions started outside Germany.

What the sachkundige Person owns

The centre of the role is batch certification: confirming that a batch was manufactured and tested in line with GMP and the marketing authorisation before it is released to market. The European frame for that act is EU GMP Annex 16. The responsibility is personal and carried by name; it can be supported, never offloaded. Day to day, that means batch record review, assessing deviations against the release decision, supply chain and import questions, and, when it comes to it, saying no to your own site director.

That is why authorities examine not only professional suitability but also, under § 14 AMG, personal reliability, and why employers treat this hire as a board-level concern.

The legal basis in brief: §§ 14, 15 and 19 AMG

§ 14(1) AMG ties the manufacturing authorisation to having at least one person with the expertise defined in § 15, able to fulfil their duties at all times. § 15 defines that expertise, in detail below. § 19 describes the scope of responsibility: ensuring each batch was manufactured and tested in accordance with the rules. All of it rests on Art. 48 and 49 of Directive 2001/83/EC. The sachkundige Person is the German Qualified Person, one role under two names, which also means the qualification logic is EU-harmonised: a QP career built in another member state translates.

The § 15 AMG expertise, in detail

The first entry ticket is the German pharmacist licence, the Approbation. It satisfies the academic requirement outright, which makes pharmacy the shortest route into the QP track. The second is a university degree of at least four years in pharmacy, chemistry, pharmaceutical chemistry and technology, biology, or human or veterinary medicine, completed with an examination. The statute also allows a variant of three and a half years of study followed by at least one year of theoretical and practical training, including six months in a community pharmacy.

Then comes the practice requirement: as a baseline, at least two years working in the qualitative and quantitative analysis and other quality testing of medicinal products. A degree of at least five years cuts that to one year; at least six years, to six months. The planning point people miss: it is analytical and testing work that counts, not any industry experience. Start in a pure documentation or systems role and those years never accumulate.

§ 15(2) adds a subject catalogue running from experimental physics through analytical and pharmaceutical chemistry to toxicology and pharmaceutical biology. If your degree missed individual subjects, that is not automatically the end; the authority assesses the evidence case by case. For biologists and chemists from programmes without a pharma slant, this is the clause worth checking your transcripts against early.

Specialised products carry their own rules: blood preparations, sera, vaccines and allergens require at least three years in medical serology or medical microbiology; gene and somatic cell therapy products at least two years in relevant fields such as genetic engineering, microbiology or cell and molecular biology; xenogeneic medicinal products three. If you are aiming at ATMPs, plan those years deliberately, because that is exactly where the candidate market is thinnest.

The realistic route: from the QC bench to the appointment

In practice I see almost always the same sequence. Entry in QC analytics, where the required testing years accumulate. Then the move into quality assurance, where batch processes, deviations and change control become daily work; how that move succeeds is covered in from lab or production into QA. After that, the deputy seat to a named sachkundige Person, the most underrated station of all, because that is where release judgement forms under supervision. Finally your own appointment toward the authority, often combined with changing employers, because a seat rarely opens internally at the right moment.

Be honest in your maths: the statutory minimum of practice years is the floor, not the reality. Employers appoint people they would trust through an inspection and a recall, and that trust builds over years spent close to batches.

Combined mandates, and where the role leads

The AMG explicitly allows the sachkundige Person to simultaneously hold the role of Stufenplanbeauftragter, Germany's national pharmacovigilance appointment. In the mid-market such combinations are common and make profiles that know both worlds unusually valuable. Strategically, the QP appointment is also the foundation for site quality director and site head tracks; the full picture of the function sits in the guide to QA and GMP careers in DACH pharma.

What a CV has to evidence for the appointment

From a recruiter's chair, batch closeness decides. A strong profile names the analysis and testing years with methods, the product types and dosage forms, sterile or non-sterile, batch record review and release support, inspection history with your role, validation and Annex 1 exposure and, if present, the deputy period with dates. The line "deputy sachkundige Person under § 14 AMG, 2023 to 2026" tells a quality director more than any task list.

The market across DACH

Germany runs one of the densest manufacturing landscapes in Europe, from originators through generics to CDMOs, and every manufacturing authorisation hangs on this role. Demand is structural and strongest where specialisation is required: sterile manufacturing, biologics, ATMPs. Austria follows the same QP logic through EU law. Switzerland runs its own regime under its therapeutic products law, with the fachtechnisch verantwortliche Person as the counterpart, so if Basel is on your map, check those requirements separately. For international QPs, one honest note: shop floors at German sites often run in German, while global quality organisations and large CDMOs frequently work in English, so your language profile shapes which sites are open to you.

A note on salary

No band here either. Compensation depends on product class, site size, sterile or non-sterile, and whether the appointment is combined with a leadership role. Two directions hold reliably: the appointment itself lifts you clearly above operational QA, and specialising toward biologics, sterile or ATMP moves the range more than any employer change within the same category.

Frequently asked questions

What degree do you need to become a Qualified Person in Germany?

Under § 15 AMG: either a German pharmacist licence (Approbation), or a university degree of at least four years in pharmacy, chemistry, pharmaceutical chemistry and technology, biology, or human or veterinary medicine. On top of that, hands-on experience in medicines analysis is mandatory. If individual subjects from the § 15(2) catalogue are missing, the authority can require additional proof.

How much practical experience does § 15 AMG require?

The baseline is at least two years of practical work in the qualitative and quantitative analysis and other quality testing of medicinal products. With a degree of at least five years the requirement drops to one year, with at least six years to six months. Blood products, sera, vaccines and allergens require three years in medical serology or medical microbiology, and gene and cell therapy products carry their own requirements under § 15(3a) AMG.

Is the sachkundige Person the same as the EU Qualified Person?

Yes. The sachkundige Person under § 14 AMG is the German implementation of the EU Qualified Person from Art. 48 of Directive 2001/83/EC. They are responsible under § 19 AMG for every batch being manufactured and tested according to the rules, with certification following EU GMP Annex 16. Without at least one sachkundige Person there is no manufacturing authorisation, and the harmonised basis means QP experience from other member states counts toward a German career.

What is the realistic career path to the QP seat?

The most common sequence: start in QC analytics to accumulate the required testing years, move into quality assurance, serve as deputy to a named QP, then take your own appointment. Pharmacists have the most direct entry via the Approbation. Profiles with sterile, biologics and Annex 1 experience are in the strongest demand.

Sources

§ 14 AMG, decision on the manufacturing authorisation (gesetze-im-internet.de, German)
§ 15 AMG, expertise (gesetze-im-internet.de, German)
§ 19 AMG, areas of responsibility (gesetze-im-internet.de, German)
Directive 2001/83/EC, Art. 48 and 49 (EUR-Lex)
EudraLex Volume 4, EU GMP incl. Annex 16 (European Commission)

© 27 July 2026 Andreas Schulz. All rights reserved. This article is career guidance, not legal advice; the statutory text prevails.